FDA inspection
Immunex Corp.: FDA inspection ending Oct 28, 2005
FDA inspection 401493 · No Action Indicated (NAI) · Thousand Oaks, CA
Key facts
| Inspection ID | 401493 |
|---|---|
| Firm | Immunex Corp. |
| FEI number | 1000125884 |
| Address | 1 Amgen Center Dr |
| City | Thousand Oaks |
| State | CA |
| ZIP | 91320-1730 |
| Fiscal year | 2006 |
| Inspection end date | Oct 28, 2005 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data